Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Conflicts of Interest in Dermatology Patient Advocacy Organizations.

Boutin M.

JAMA Dermatol. 2019 Jun 26. doi: 10.1001/jamadermatol.2019.1655. [Epub ahead of print] No abstract available.

PMID:
31241729
2.

Mutation-specific Fabry disease patient-derived cell model to evaluate the amenability to chaperone therapy.

Lenders M, Stappers F, Niemietz C, Schmitz B, Boutin M, Ballmaier PJ, Zibert A, Schmidt H, Brand SM, Auray-Blais C, Brand E.

J Med Genet. 2019 Apr 22. pii: jmedgenet-2019-106005. doi: 10.1136/jmedgenet-2019-106005. [Epub ahead of print]

PMID:
31010832
3.

Distribution of heparan sulfate and dermatan sulfate in mucopolysaccharidosis type II mouse tissues pre- and post-enzyme-replacement therapy determined by UPLC-MS/MS.

Menkovic I, Lavoie P, Boutin M, Auray-Blais C.

Bioanalysis. 2019 Apr;11(8):727-740. doi: 10.4155/bio-2018-0306. Epub 2019 Apr 17.

PMID:
30994022
4.

Altered immune phenotypes in subjects with Fabry disease and responses to switching from agalsidase alfa to agalsidase beta.

Limgala RP, Jennelle T, Plassmeyer M, Boutin M, Lavoie P, Abaoui M, Auray-Blais C, Nedd K, Alpan O, Goker-Alpan O.

Am J Transl Res. 2019 Mar 15;11(3):1683-1696. eCollection 2019.

5.

Tandem mass spectrometry analysis of urinary podocalyxin and podocin in the investigation of podocyturia in women with preeclampsia and Fabry disease patients.

Martineau T, Boutin M, Côté AM, Maranda B, Bichet DG, Auray-Blais C.

Clin Chim Acta. 2019 Aug;495:67-75. doi: 10.1016/j.cca.2019.03.1615. Epub 2019 Mar 19.

PMID:
30898510
6.

Elevated Inflammatory Plasma Biomarkers in Patients With Fabry Disease: A Critical Link to Heart Failure With Preserved Ejection Fraction.

Yogasundaram H, Nikhanj A, Putko BN, Boutin M, Jain-Ghai S, Khan A, Auray-Blais C, West ML, Oudit GY.

J Am Heart Assoc. 2018 Nov 6;7(21):e009098. doi: 10.1161/JAHA.118.009098.

7.

Recognizing that Evidence is Made, not Born.

Lim R, Lee DK, Sabourin P, Ferguson J, Metcalf M, Smith M, Corriol-Rohou S, Eichler HG, Lumpkin M, Hirsch G, Chen IM, O'Rourke B, Schiel A, Crabb N, Aronson N, Pezalla E, Boutin M, Binder L, Wilhelm L.

Clin Pharmacol Ther. 2019 Apr;105(4):844-856. doi: 10.1002/cpt.1317. Epub 2019 Jan 4.

8.

Contribution of plant species to the high N retention capacity of a subalpine meadow undergoing elevated N deposition and warming.

Pornon A, Boutin M, Lamaze T.

Environ Pollut. 2019 Feb;245:235-242. doi: 10.1016/j.envpol.2018.10.027. Epub 2018 Nov 2.

PMID:
30423538
9.

A high-throughput imaging and nuclear segmentation analysis protocol for cleared 3D culture models.

Boutin ME, Voss TC, Titus SA, Cruz-Gutierrez K, Michael S, Ferrer M.

Sci Rep. 2018 Jul 24;8(1):11135. doi: 10.1038/s41598-018-29169-0.

10.

What do stakeholders expect from patient engagement: Are these expectations being met?

Boudes M, Robinson P, Bertelsen N, Brooke N, Hoos A, Boutin M, Geissler J, Sargeant I.

Health Expect. 2018 Dec;21(6):1035-1045. doi: 10.1111/hex.12797. Epub 2018 Jun 1.

11.

Heliox Adjunct Therapy for Neonates With Congenital Diaphragmatic Hernia.

Wise AC, Boutin MA, Knodel EM, Proudfoot JA, Lane BP, Evans ML, Suttner DM, Kimball AL.

Respir Care. 2018 Sep;63(9):1147-1153. doi: 10.4187/respcare.06079. Epub 2018 May 22.

PMID:
29789411
12.

Analysis of globotriaosylceramide (Gb3) isoforms/analogs in unfractionated leukocytes, B lymphocytes and monocytes from Fabry patients using ultra-high performance liquid chromatography/tandem mass spectrometry.

Toupin A, Lavoie P, Arthus MF, Abaoui M, Boutin M, Fortier C, Ménard C, Bichet DG, Auray-Blais C.

Anal Chim Acta. 2018 Jul 26;1015:35-49. doi: 10.1016/j.aca.2018.02.022. Epub 2018 Feb 19.

PMID:
29530250
13.

Multi-tissue transcriptomic study reveals the main role of liver in the chicken adaptive response to a switch in dietary energy source through the transcriptional regulation of lipogenesis.

Desert C, Baéza E, Aite M, Boutin M, Le Cam A, Montfort J, Houee-Bigot M, Blum Y, Roux PF, Hennequet-Antier C, Berri C, Metayer-Coustard S, Collin A, Allais S, Le Bihan E, Causeur D, Gondret F, Duclos MJ, Lagarrigue S.

BMC Genomics. 2018 Mar 7;19(1):187. doi: 10.1186/s12864-018-4520-5.

14.

Frequent contamination of nursing scrubs is associated with specific care activities.

Thom KA, Escobar D, Boutin MA, Zhan M, Harris AD, Johnson JK.

Am J Infect Control. 2018 May;46(5):503-506. doi: 10.1016/j.ajic.2017.11.016. Epub 2018 Jan 11.

PMID:
29336847
15.

Globotriaosylsphingosine (Lyso-Gb3) as a biomarker for cardiac variant (N215S) Fabry disease.

Alharbi FJ, Baig S, Auray-Blais C, Boutin M, Ward DG, Wheeldon N, Steed R, Dawson C, Hughes D, Geberhiwot T.

J Inherit Metab Dis. 2018 Mar;41(2):239-247. doi: 10.1007/s10545-017-0127-2. Epub 2018 Jan 2.

PMID:
29294190
16.

Letter to the Editor: Emerging Guidelines for Patient Engagement in Research.

Boutin M, Dewulf L.

Value Health. 2017 Dec;20(10):1431-1432. doi: 10.1016/j.jval.2017.06.010. Epub 2017 Aug 24. No abstract available.

17.

The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synuclein.

Nelson MP, Boutin M, Tse TE, Lu H, Haley ED, Ouyang X, Zhang J, Auray-Blais C, Shacka JJ.

Neurobiol Dis. 2018 Feb;110:68-81. doi: 10.1016/j.nbd.2017.11.006. Epub 2017 Dec 2.

18.

Separation and Analysis of Lactosylceramide, Galabiosylceramide, and Globotriaosylceramide by LC-MS/MS in Urine of Fabry Disease Patients.

Boutin M, Menkovic I, Martineau T, Vaillancourt-Lavigueur V, Toupin A, Auray-Blais C.

Anal Chem. 2017 Dec 19;89(24):13382-13390. doi: 10.1021/acs.analchem.7b03609. Epub 2017 Nov 27.

PMID:
29099167
19.

[Identification of proteins associated with transcription factors HOXA9 and E2A-PBX1 by tandem affinity purification].

Shestakova EA, Boutin M, Bourassa S, Bonneil E, Bijl JJ.

Mol Biol (Mosk). 2017 May-Jun;51(3):490-501. doi: 10.7868/S0026898417030132. Russian.

20.

Lentivector Iterations and Pre-Clinical Scale-Up/Toxicity Testing: Targeting Mobilized CD34+ Cells for Correction of Fabry Disease.

Huang J, Khan A, Au BC, Barber DL, López-Vásquez L, Prokopishyn NL, Boutin M, Rothe M, Rip JW, Abaoui M, Nagree MS, Dworski S, Schambach A, Keating A, West ML, Klassen J, Turner PV, Sirrs S, Rupar CA, Auray-Blais C, Foley R, Medin JA.

Mol Ther Methods Clin Dev. 2017 May 12;5:241-258. doi: 10.1016/j.omtm.2017.05.003. eCollection 2017 Jun 16.

21.

Wide Variability in Caloric Density of Expressed Human Milk Can Lead to Major Underestimation or Overestimation of Nutrient Content.

Sauer CW, Boutin MA, Kim JH.

J Hum Lact. 2017 May;33(2):341-350. doi: 10.1177/0890334416672200. Epub 2016 Dec 1.

PMID:
28418793
22.

High-Risk Screening for Fabry Disease: Analysis by Tandem Mass Spectrometry of Globotriaosylceramide (Gb3 ) in Urine Collected on Filter Paper.

Auray-Blais C, Lavoie P, Boutin M, Abaoui M.

Curr Protoc Hum Genet. 2017 Apr 6;93:17.26.1-17.26.12. doi: 10.1002/cphg.34.

PMID:
28384397
23.

Advancing Value Assessment in the United States: A Multistakeholder Perspective.

Sorenson C, Lavezzari G, Daniel G, Burkholder R, Boutin M, Pezalla E, Sanders G, McClellan M.

Value Health. 2017 Feb;20(2):299-307. doi: 10.1016/j.jval.2016.11.030.

24.

Value to Whom? The Patient Voice in the Value Discussion.

Perfetto EM, Oehrlein EM, Boutin M, Reid S, Gascho E.

Value Health. 2017 Feb;20(2):286-291. doi: 10.1016/j.jval.2016.11.014.

25.

Culture and Process Change as a Priority for Patient Engagement in Medicines Development.

Boutin M, Dewulf L, Hoos A, Geissler J, Todaro V, Schneider RF, Garzya V, Garvey A, Robinson P, Saffer T, Krug S, Sargeant I.

Ther Innov Regul Sci. 2017 Jan;51(1):29-38. doi: 10.1177/2168479016659104. Epub 2016 Aug 20.

26.

A three-dimensional neural spheroid model for capillary-like network formation.

Boutin ME, Kramer LL, Livi LL, Brown T, Moore C, Hoffman-Kim D.

J Neurosci Methods. 2018 Apr 1;299:55-63. doi: 10.1016/j.jneumeth.2017.01.014. Epub 2017 Jan 29.

PMID:
28143748
27.

Glycosphingolipid storage in Fabry mice extends beyond globotriaosylceramide and is affected by ABCB1 depletion.

Kamani MA, Provençal P, Boutin M, Pacienza N, Fan X, Novak A, Huang TC, Binnington B, Au BC, Auray-Blais C, Lingwood CA, Medin JA.

Future Sci OA. 2016 Oct 13;2(4):FSO147. doi: 10.4155/fsoa-2016-0027. eCollection 2016 Dec.

28.

Biomarkers associated with clinical manifestations in Fabry disease patients with a late-onset cardiac variant mutation.

Auray-Blais C, Lavoie P, Boutin M, Ntwari A, Hsu TR, Huang CK, Niu DM.

Clin Chim Acta. 2017 Mar;466:185-193. doi: 10.1016/j.cca.2017.01.018. Epub 2017 Jan 18.

PMID:
28108302
29.

Long noncoding RNA repertoire in chicken liver and adipose tissue.

Muret K, Klopp C, Wucher V, Esquerré D, Legeai F, Lecerf F, Désert C, Boutin M, Jehl F, Acloque H, Giuffra E, Djebali S, Foissac S, Derrien T, Lagarrigue S.

Genet Sel Evol. 2017 Jan 10;49(1):6. doi: 10.1186/s12711-016-0275-0.

30.

Delivery Room Quality Improvement Project Improved Compliance with Best Practices for a Community NICU.

Sauer CW, Boutin MA, Fatayerji AN, Proudfoot JA, Fatayerji NI, Golembeski DJ.

Sci Rep. 2016 Nov 21;6:37397. doi: 10.1038/srep37397.

31.

Innovation in Medicine and Device Development, Regulatory Review, and Use of Clinical Advances.

Rosenblatt M, Boutin MM, Nussbaum SR.

JAMA. 2016 Oct 25;316(16):1671-1672. doi: 10.1001/jama.2016.12486. No abstract available.

PMID:
27669080
32.

Inadvertent Methylergonovine Administration to a Neonate.

Corbett BM, O'Connell C, Boutin MA, Fatayerji NI, Sauer CW.

Am J Case Rep. 2016 Oct 21;17:770-773.

33.

High-Risk Screening of Fabry Disease: Analysis of Fifteen Urinary Methylated and Non-Methylated Gb3 Isoforms Using Tandem Mass Spectrometry.

Abaoui M, Boutin M, Lavoie P, Auray-Blais C.

Curr Protoc Hum Genet. 2016 Oct 11;91:17.24.1-17.24.11. doi: 10.1002/cphg.24.

PMID:
27727434
34.

Protein characterization of intracellular target-sorted, formalin-fixed cell subpopulations.

Sadick JS, Boutin ME, Hoffman-Kim D, Darling EM.

Sci Rep. 2016 Sep 26;6:33999. doi: 10.1038/srep33999.

35.

Relative distribution of Gb3 isoforms/analogs in NOD/SCID/Fabry mice tissues determined by tandem mass spectrometry.

Provençal P, Boutin M, Dworski S, Au B, Medin JA, Auray-Blais C.

Bioanalysis. 2016 Sep;8(17):1793-807. doi: 10.4155/bio-2016-0116. Epub 2016 Aug 15.

36.

Intubation Attempts Increase the Risk for Severe Intraventricular Hemorrhage in Preterm Infants-A Retrospective Cohort Study.

Sauer CW, Kong JY, Vaucher YE, Finer N, Proudfoot JA, Boutin MA, Leone TA.

J Pediatr. 2016 Oct;177:108-113. doi: 10.1016/j.jpeds.2016.06.051. Epub 2016 Jul 26.

PMID:
27470688
37.

Tandem Mass Spectrometry Quantitation of Lyso-Gb3 and Six Related Analogs in Plasma for Fabry Disease Patients.

Boutin M, Lavoie P, Abaoui M, Auray-Blais C.

Curr Protoc Hum Genet. 2016 Jul 1;90:17.23.1-9. doi: 10.1002/cphg.4.

PMID:
27367163
38.

Fabry Disease Biomarkers: Analysis of Urinary Lyso-Gb3 and Seven Related Analogs Using Tandem Mass Spectrometry.

Lavoie P, Boutin M, Abaoui M, Auray-Blais C.

Curr Protoc Hum Genet. 2016 Jul 1;90:17.22.1-17.22.12. doi: 10.1002/cphg.1.

PMID:
27367162
39.

Maternal inhaled fluticasone propionate intake during pregnancy is detected in neonatal cord blood.

Battista MC, Boutin M, Venne P, Blais L, Bérard A, Lacroix M, Patenaude J, Guillemette L, Cossette B, Hivert MF, Auray-Blais C.

Bioanalysis. 2016 Jul;8(14):1441-1450. Epub 2016 Jun 28.

PMID:
27349687
40.

Diagnosis of late-onset Pompe disease and other muscle disorders by next-generation sequencing.

Lévesque S, Auray-Blais C, Gravel E, Boutin M, Dempsey-Nunez L, Jacques PE, Chenier S, Larue S, Rioux MF, Al-Hertani W, Nadeau A, Mathieu J, Maranda B, Désilets V, Waters PJ, Keutzer J, Austin S, Kishnani P.

Orphanet J Rare Dis. 2016 Jan 25;11:8. doi: 10.1186/s13023-016-0390-6.

41.

Evaluation of urinary keratan sulfate disaccharides in MPS IVA patients using UPLC-MS/MS.

Auray-Blais C, Lavoie P, Maranda B, Boutin M.

Bioanalysis. 2016 Feb;8(3):179-91. doi: 10.4155/bio.15.239. Epub 2016 Jan 25.

PMID:
26805456
42.

Tandem Mass Spectrometry Multiplex Analysis of Glucosylceramide and Galactosylceramide Isoforms in Brain Tissues at Different Stages of Parkinson Disease.

Boutin M, Sun Y, Shacka JJ, Auray-Blais C.

Anal Chem. 2016 Feb 2;88(3):1856-63. doi: 10.1021/acs.analchem.5b04227. Epub 2016 Jan 21.

PMID:
26735924
43.

The Extent of mRNA Editing Is Limited in Chicken Liver and Adipose, but Impacted by Tissular Context, Genotype, Age, and Feeding as Exemplified with a Conserved Edited Site in COG3.

Roux PF, Frésard L, Boutin M, Leroux S, Klopp C, Djari A, Esquerré D, Martin PG, Zerjal T, Gourichon D, Pitel F, Lagarrigue S.

G3 (Bethesda). 2015 Dec 4;6(2):321-35. doi: 10.1534/g3.115.022251.

44.

Tandem mass spectrometry multiplex analysis of methylated and non-methylated urinary Gb3 isoforms in Fabry disease patients.

Abaoui M, Boutin M, Lavoie P, Auray-Blais C.

Clin Chim Acta. 2016 Jan 15;452:191-8. doi: 10.1016/j.cca.2015.11.018. Epub 2015 Nov 22.

PMID:
26593248
45.

Partnering With Patients in the Development and Lifecycle of Medicines: A Call for Action.

Hoos A, Anderson J, Boutin M, Dewulf L, Geissler J, Johnston G, Joos A, Metcalf M, Regnante J, Sargeant I, Schneider RF, Todaro V, Tougas G.

Ther Innov Regul Sci. 2015 Nov;49(6):929-939.

46.

Three-Dimensional Neural Spheroid Culture: An In Vitro Model for Cortical Studies.

Dingle YT, Boutin ME, Chirila AM, Livi LL, Labriola NR, Jakubek LM, Morgan JR, Darling EM, Kauer JA, Hoffman-Kim D.

Tissue Eng Part C Methods. 2015 Dec;21(12):1274-83. doi: 10.1089/ten.TEC.2015.0135. Epub 2015 Oct 6.

47.

Low-severity fire increases tree defense against bark beetle attacks.

Hood S, Sala A, Heyerdahl EK, Boutin M.

Ecology. 2015 Jul;96(7):1846-55.

PMID:
26378307
48.

Subalpine Pyrenees received higher nitrogen deposition than predicted by EMEP and CHIMERE chemistry-transport models.

Boutin M, Lamaze T, Couvidat F, Pornon A.

Sci Rep. 2015 Aug 10;5:12942. doi: 10.1038/srep12942.

49.

Deriving nutrition information using mathematical estimation: the example of phenylalanine in sweets with gelatin.

Kim J, Boutin M.

J Acad Nutr Diet. 2015 Sep;115(9):1384-6. doi: 10.1016/j.jand.2015.05.018. Epub 2015 Jul 18. No abstract available.

PMID:
26198583
50.

Variations in the GLA gene correlate with globotriaosylceramide and globotriaosylsphingosine analog levels in urine and plasma.

Ferreira S, Auray-Blais C, Boutin M, Lavoie P, Nunes JP, Martins E, Garman S, Oliveira JP.

Clin Chim Acta. 2015 Jul 20;447:96-104. doi: 10.1016/j.cca.2015.06.003. Epub 2015 Jun 9.

Supplemental Content

Loading ...
Support Center